Wuchter P - Search Results

1

Plerixafor induces the rapid and transient release of stromal cell-derived factor-1 alpha from human mesenchymal stromal cells and influences the migration behavior of human hematopoietic progenitor cells.

Wuchter P, Leinweber C, Saffrich R, Hanke M, Eckstein V, Ho AD, Grunze M, Rosenhahn A. Wuchter P, et al. Cell Tissue Res. 2014 Feb;355(2):315-26. doi: 10.1007/s00441-013-1759-7. Epub 2013 Dec 14. Cell Tissue Res. 2014. PMID: 24337688

2

SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays.

Seidel A, Hoffmann S, Jahrsdörfer B, Körper S, Ludwig C, Vieweg C, Albers D, von Maltitz P, Müller R, Lotfi R, Wuchter P, Klüter H, Kirchhoff F, Schmidt M, Münch J, Schrezenmeier H. Seidel A, et al. Among authors: wuchter p. Front Immunol. 2023 Apr 25;14:1170759. doi: 10.3389/fimmu.2023.1170759. eCollection 2023. Front Immunol. 2023. PMID: 37180152 Free PMC article.

3

One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients.

Körper S, Grüner B, Zickler D, Wiesmann T, Wuchter P, Blasczyk R, Zacharowski K, Spieth P, Tonn T, Rosenberger P, Paul G, Pilch J, Schwäble J, Bakchoul T, Thiele T, Knörlein J, Dollinger MM, Krebs J, Bentz M, Corman VM, Kilalic D, Schmidtke-Schrezenmeier G, Lepper PM, Ernst L, Wulf H, Ulrich A, Weiss M, Kruse JM, Burkhardt T, Müller R, Klüter H, Schmidt M, Jahrsdörfer B, Lotfi R, Rojewski M, Appl T, Mayer B, Schnecko P, Seifried E, Schrezenmeier H. Körper S, et al. Among authors: wuchter p. J Clin Invest. 2022 Dec 15;132(24):e163657. doi: 10.1172/JCI163657. J Clin Invest. 2022. PMID: 36326824 Free PMC article. Clinical Trial.

4

The heterogeneity of human mesenchymal stem cell preparations--evidence from simultaneous analysis of proteomes and transcriptomes.

Wagner W, Feldmann RE Jr, Seckinger A, Maurer MH, Wein F, Blake J, Krause U, Kalenka A, Bürgers HF, Saffrich R, Wuchter P, Kuschinsky W, Ho AD. Wagner W, et al. Among authors: wuchter p. Exp Hematol. 2006 Apr;34(4):536-48. doi: 10.1016/j.exphem.2006.01.002. Exp Hematol. 2006. PMID: 16569600 Free article.

5

Processus and recessus adhaerentes: giant adherens cell junction systems connect and attract human mesenchymal stem cells.

Wuchter P, Boda-Heggemann J, Straub BK, Grund C, Kuhn C, Krause U, Seckinger A, Peitsch WK, Spring H, Ho AD, Franke WW. Wuchter P, et al. Cell Tissue Res. 2007 Jun;328(3):499-514. doi: 10.1007/s00441-007-0379-5. Epub 2007 Mar 20. Cell Tissue Res. 2007. PMID: 17372769

6

[Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma].

Kasper B, Schmitt T, Wuchter P, Ho AD, Egerer G. Kasper B, et al. Among authors: wuchter p. Dtsch Med Wochenschr. 2009 Sep;134(39):1922-6. doi: 10.1055/s-0029-1237531. Epub 2009 Sep 16. Dtsch Med Wochenschr. 2009. PMID: 19760551 German.

7

Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes.

Ran D, Schubert M, Pietsch L, Taubert I, Wuchter P, Eckstein V, Bruckner T, Zoeller M, Ho AD. Ran D, et al. Among authors: wuchter p. Exp Hematol. 2009 Dec;37(12):1423-34. doi: 10.1016/j.exphem.2009.10.001. Epub 2009 Oct 9. Exp Hematol. 2009. PMID: 19819294

8

The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.

Kasper B, Schmitt T, Wuchter P, Dimitrakopoulou-Strauss A, Ho AD, Egerer G. Kasper B, et al. Among authors: wuchter p. Mar Drugs. 2009 Jul 17;7(3):331-40. doi: 10.3390/md7030331. Mar Drugs. 2009. PMID: 19841717 Free PMC article.

9

Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation.

Wuchter P, Ran D, Bruckner T, Schmitt T, Witzens-Harig M, Neben K, Goldschmidt H, Ho AD. Wuchter P, et al. Biol Blood Marrow Transplant. 2010 Apr;16(4):490-9. doi: 10.1016/j.bbmt.2009.11.012. Epub 2009 Nov 17. Biol Blood Marrow Transplant. 2010. PMID: 19925876 Free article.

10

A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study.

Fruehauf S, Veldwijk MR, Seeger T, Schubert M, Laufs S, Topaly J, Wuchter P, Dillmann F, Eckstein V, Wenz F, Goldschmidt H, Ho AD, Calandra G. Fruehauf S, et al. Among authors: wuchter p. Cytotherapy. 2009;11(8):992-1001. doi: 10.3109/14653240903121245. Cytotherapy. 2009. PMID: 19929463 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page